MYGN logo

Myriad Genetics (MYGN) Shareholders Equity

Annual Shareholders Equity

$783.20 M
-$102.60 M-11.58%

01 December 2023

MYGN Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$731.70 M
-$8.80 M-1.19%

01 September 2024

MYGN Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

MYGN Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--6.6%
3 y3 years-11.1%-24.5%
5 y5 years-28.1%-31.9%

MYGN Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-19.1%at low-24.5%+7.1%
5 y5 years-28.1%at low-32.1%+7.1%
alltimeall time-28.1%+1524.9%-33.6%+1418.0%

Myriad Genetics Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$731.70 M(-1.2%)
June 2024
-
$740.50 M(-2.6%)
Mar 2024
-
$760.00 M(-3.0%)
Dec 2023
$783.20 M(-11.6%)
$783.20 M(+14.6%)
Sept 2023
-
$683.40 M(-7.0%)
June 2023
-
$735.20 M(-12.0%)
Mar 2023
-
$835.20 M(-5.7%)
Dec 2022
$885.80 M(-8.5%)
$885.80 M(-3.4%)
Sept 2022
-
$916.60 M(-3.3%)
June 2022
-
$947.40 M(-0.3%)
Mar 2022
-
$950.10 M(-1.8%)
Dec 2021
$967.80 M(+9.9%)
$967.80 M(-0.1%)
Sept 2021
-
$968.60 M(+7.3%)
June 2021
-
$902.50 M(+3.1%)
Mar 2021
-
$875.20 M(-3.8%)
Dec 2020
$881.00 M(-4.1%)
-
Sept 2020
-
$909.30 M(-1.0%)
June 2020
$918.20 M(-15.7%)
$918.20 M(-5.1%)
Mar 2020
-
$967.20 M(-10.2%)
Dec 2019
-
$1.08 B(+0.3%)
Sept 2019
-
$1.07 B(-1.3%)
June 2019
$1.09 B(+12.7%)
$1.09 B(+0.7%)
Mar 2019
-
$1.08 B(+1.7%)
Dec 2018
-
$1.06 B(-3.4%)
Sept 2018
-
$1.10 B(+14.1%)
June 2018
$966.10 M(+25.7%)
$966.10 M(+1.9%)
Mar 2018
-
$948.30 M(+3.7%)
Dec 2017
-
$914.20 M(+5.0%)
Sept 2017
-
$870.90 M(+13.3%)
June 2017
$768.40 M(+2.7%)
$768.40 M(+2.7%)
Mar 2017
-
$748.20 M(+2.1%)
Dec 2016
-
$732.90 M(-0.4%)
Sept 2016
-
$735.50 M(-1.7%)
June 2016
$748.10 M(+13.0%)
$748.10 M(-2.9%)
Mar 2016
-
$770.20 M(-0.1%)
Dec 2015
-
$770.80 M(+12.2%)
Sept 2015
-
$687.10 M(+3.8%)
June 2015
$662.10 M(-7.9%)
$662.10 M(-1.0%)
Mar 2015
-
$668.90 M(-3.7%)
Dec 2014
-
$694.24 M(-2.5%)
Sept 2014
-
$712.15 M(-1.0%)
June 2014
$719.00 M(-1.3%)
$719.00 M(-0.4%)
Mar 2014
-
$722.24 M(+6.8%)
Dec 2013
-
$675.97 M(-2.1%)
Sept 2013
-
$690.27 M(-5.3%)
June 2013
$728.59 M(+14.6%)
$728.59 M(+9.6%)
Mar 2013
-
$664.93 M(+0.4%)
Dec 2012
-
$662.12 M(+4.2%)
Sept 2012
-
$635.57 M(-0.0%)
June 2012
$635.66 M(+12.2%)
$635.66 M(-2.5%)
Mar 2012
-
$652.19 M(+5.7%)
Dec 2011
-
$616.76 M(+6.5%)
Sept 2011
-
$578.99 M(+2.2%)
June 2011
$566.79 M(+1.7%)
$566.79 M(+8.1%)
Mar 2011
-
$524.46 M(-6.5%)
Dec 2010
-
$561.10 M(-1.8%)
Sept 2010
-
$571.11 M(+2.4%)
June 2010
$557.58 M
$557.58 M(-1.7%)
DateAnnualQuarterly
Mar 2010
-
$567.35 M(+9.7%)
Dec 2009
-
$517.33 M(+9.3%)
Sept 2009
-
$473.14 M(+9.0%)
June 2009
$434.22 M(+2.0%)
$434.22 M(-25.6%)
Mar 2009
-
$583.93 M(+12.3%)
Dec 2008
-
$519.75 M(+9.0%)
Sept 2008
-
$477.04 M(+12.1%)
June 2008
$425.65 M(+25.1%)
$425.65 M(+20.5%)
Mar 2008
-
$353.30 M(+1.1%)
Dec 2007
-
$349.47 M(+2.3%)
Sept 2007
-
$341.75 M(+0.4%)
June 2007
$340.36 M(+36.3%)
$340.36 M(+0.3%)
Mar 2007
-
$339.19 M(+43.8%)
Dec 2006
-
$235.85 M(-1.7%)
Sept 2006
-
$239.87 M(-4.0%)
June 2006
$249.78 M(+84.1%)
$249.78 M(-2.7%)
Mar 2006
-
$256.70 M(-1.9%)
Dec 2005
-
$261.65 M(+104.9%)
Sept 2005
-
$127.69 M(-5.9%)
June 2005
$135.67 M(-21.7%)
$135.67 M(-5.8%)
Mar 2005
-
$144.04 M(-6.5%)
Dec 2004
-
$154.00 M(-5.9%)
Sept 2004
-
$163.62 M(-5.6%)
June 2004
$173.28 M(+6.0%)
$173.28 M(+29.8%)
Mar 2004
-
$133.49 M(-7.4%)
Dec 2003
-
$144.10 M(-6.3%)
Sept 2003
-
$153.77 M(-5.9%)
June 2003
$163.49 M(+26.9%)
$163.49 M(-3.8%)
Mar 2003
-
$170.00 M(-3.1%)
Dec 2002
-
$175.44 M(+41.5%)
Sept 2002
-
$124.02 M(-3.8%)
June 2002
$128.87 M(-7.7%)
$128.87 M(-4.4%)
Mar 2002
-
$134.74 M(-2.8%)
Dec 2001
-
$138.57 M(-0.5%)
Sept 2001
-
$139.27 M(-0.2%)
June 2001
$139.56 M(+79.6%)
$139.56 M(+0.2%)
Mar 2001
-
$139.23 M(-0.4%)
Dec 2000
-
$139.78 M(+42.3%)
Sept 2000
-
$98.20 M(+26.4%)
June 2000
$77.71 M(+61.2%)
$77.71 M(+40.6%)
Mar 2000
-
$55.25 M(-0.4%)
Dec 1999
-
$55.50 M(+9.3%)
Sept 1999
-
$50.80 M(+5.4%)
June 1999
$48.20 M(-16.2%)
$48.20 M(-4.4%)
Mar 1999
-
$50.40 M(-4.0%)
Dec 1998
-
$52.50 M(-4.5%)
Sept 1998
-
$55.00 M(-4.3%)
June 1998
$57.50 M(-13.1%)
$57.50 M(-4.6%)
Mar 1998
-
$60.30 M(-4.0%)
Dec 1997
-
$62.80 M(-2.8%)
Sept 1997
-
$64.60 M(-2.4%)
June 1997
$66.20 M(-5.7%)
$66.20 M(+7.6%)
Mar 1997
-
$61.50 M(-4.4%)
Dec 1996
-
$64.30 M(-4.9%)
Sept 1996
-
$67.60 M(-3.7%)
June 1996
$70.20 M
$70.20 M(-2.2%)
Mar 1996
-
$71.80 M(-2.2%)
Dec 1995
-
$73.40 M

FAQ

  • What is Myriad Genetics annual stockholders equity?
  • What is the all time high annual shareholders equity for Myriad Genetics?
  • What is Myriad Genetics quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Myriad Genetics?
  • What is Myriad Genetics quarterly shareholders equity year-on-year change?

What is Myriad Genetics annual stockholders equity?

The current annual shareholders equity of MYGN is $783.20 M

What is the all time high annual shareholders equity for Myriad Genetics?

Myriad Genetics all-time high annual stockholders equity is $1.09 B

What is Myriad Genetics quarterly stockholders equity?

The current quarterly shareholders equity of MYGN is $731.70 M

What is the all time high quarterly shareholders equity for Myriad Genetics?

Myriad Genetics all-time high quarterly stockholders equity is $1.10 B

What is Myriad Genetics quarterly shareholders equity year-on-year change?

Over the past year, MYGN quarterly stockholders equity has changed by -$51.50 M (-6.58%)